SUBSCRIBE
SUBSCRIBE

Preclinical

Drug Development
Can Human Head Transplant Become A Reality? Scientist Plans To Test Procedure By December 2017
May 2, 2017
 · 
1 min read
Drug Development
Can Scientists Rejuvenate An Aging Brain With Young Blood? Stanford University Study
April 20, 2017
 · 
1 min read
Halozyme Therapeutics CEO: PEGPH20 Bolsters Checkpoint Inhibitors in Preclinical Data
Drug Development
Halozyme CEO: PEGPH20 Bolsters Checkpoint Inhibitors in Preclinical Data
April 6, 2017
 · 
4 min read
Drug Development
Old Blood Can Be Made Young Again, University of Ulm Scientists Reveal
March 24, 2017
 · 
1 min read
Intellia’s CEO Has Cambridge-based Company Moving Forward on Positive in vivo Data
Drug Development
Intellia’s CEO Has Cambridge-Based Company Moving Forward on Positive in vivo Data
March 20, 2017
 · 
4 min read
Drug Development
Artificial Embryo Shows Early Potential For Medical Therapies, Not Babies, Cambridge University Study Reveals
March 3, 2017
 · 
1 min read
Drug Development
This Is Big News For Diabetics And Biotech Investors
March 2, 2017
 · 
1 min read
Biotech Vets Launch Arrakis With $38 Million and Will be Helmed By Biogen Alum Michael Gilman
Drug Development
Top Harvard Scientist Retracts Diabetes Breakthrough Paper
December 28, 2016
 · 
2 min read
Mylan Inc., Theravance, Inc. Partner Up for $265 Million COPD Pact
Business
Novartis AG and Google’s Verily Miss Smart Contact Lens Human Trial Goal
November 21, 2016
 · 
3 min read
Drug Development
Stanford University Researchers Use CRISPR to Repair Gene That Cause Sickle Cell, Human Trials Planned
November 8, 2016
 · 
5 min read
Load More
PRESS RELEASES
Press Releases
Vividion Publishes Discovery of First-in-Class KEAP1 Activator, Supporting Ongoing Clinical Program in Oncology
December 23, 2025
 · 
3 min read
Press Releases
Mondego Bio Announces Selection of a PTPN2 Inhibitor Clinical Candidate and Targets First-in-Human Trials in H1 2026
December 22, 2025
 · 
3 min read
Press Releases
Abivax Announces Acceptance of 22 Abstracts Evaluating Obefazimod in Inflammatory Bowel Disease at ECCO 2026, Featuring an Oral Presentation on Preclinical Anti-Fibrotic Findings
December 18, 2025
 · 
14 min read
Press Releases
Singlera Genomics announces research collaboration with the University of Pittsburgh to advance pancreatic cancer early detection
December 18, 2025
 · 
2 min read
Press Releases
Zelluna Reaches Major Milestone and Submits Clinical Trial Application in the UK for First-in-Human Study of ZI-MA4-1 (ZIMA-101), the World’s First MAGE-A4-Targeting TCR-NK Cell Therapy for Solid Tumours
December 18, 2025
 · 
4 min read
Press Releases
Zelluna Publishes Compelling Preclinical Data for ZI-MA4-1, the World’s First MAGE-A4-Targeting TCR-NK Therapy for Solid Tumours
December 16, 2025
 · 
4 min read
Press Releases
Feinstein Institutes’ Researchers Develop Promising Therapeutic for Sepsis-Induced Acute Lung Injury
December 16, 2025
 · 
4 min read
Press Releases
IO Biotech Announces Publication of Five-year Clinical Outcomes of Phase 1/2 Trial in Nature Communications
December 16, 2025
 · 
6 min read
Press Releases
Atelerix Enters Agreement with Cherry Biotech to Integrate Non-cryogenic Transport Solutions With Advanced Organoid Models
December 15, 2025
 · 
2 min read
Press Releases
LIR Life Sciences Files Provisional Patent Application for Needle-Free Delivery of GLP/GIP-Based Obesity Therapies
December 12, 2025
 · 
5 min read
Press Releases
Io Therapeutics, Inc., presents today at the San Antonio Breast Cancer Symposium preclinical studies demonstrating effectiveness of IRX4204, the company’s clinical stage retinoid X nuclear receptor (RXR) agonist compound, for synergistically promoting killing of HER2+ breast cancer cells in combination with HER2-targeted chimeric antigen receptor modified T-cells (CAR-T).
December 12, 2025
 · 
3 min read
Press Releases
NiKang Therapeutics Presents Discovery of NKT5097, a First-in-Class, Highly Potent and Selective, Orally Bioavailable CDK2/4 Dual Degrader for Cancer Therapy at SABCS 2025
December 12, 2025
 · 
3 min read
Press Releases
Polyrizon Announces Promising Permeation Kinetics Supporting Advancement of Its Intranasal Naloxone Hydrogel Program
December 12, 2025
 · 
6 min read
Press Releases
Lexicon Pharmaceuticals Announces Publication of Preclinical Data in the Journal of the Endocrine Society on Acyl-CoA Synthetase 5 (ACSL5) Reinforcing the Scientific Rationale for LX9851
December 11, 2025
 · 
5 min read
Press Releases
MED Institute and Sus Clinicals Announce Strategic Collaboration to Advance Preclinical Testing for Medical Product Innovation
December 11, 2025
 · 
2 min read
Press Releases
BBOT Announces Late-Breaking Preclinical Data on BBO-10203, a First-in-Class RAS:PI3Kα Breaker, at the San Antonio Breast Cancer Symposium (SABCS)
December 11, 2025
 · 
7 min read
Press Releases
IDEAYA Biosciences Announces IND Submission for IDE574, a Potential First-In-Class KAT6/7 Dual Inhibitor for Breast and Lung Cancers
December 10, 2025
 · 
4 min read
Press Releases
Innovent Announces First Participant Dosed in a Phase 1 Clinical Trial of IBI3011, a Recombinant Anti-Human Interleukin 1 Receptor Accessory Protein Monoclonal Antibody
December 10, 2025
 · 
7 min read
Press Releases
Akari Therapeutics Highlights Preclinical Data Demonstrating Therapeutic Potential of Lead Candidate, AKTX-101, for Hard-to-Treat K-Ras Mutant Pancreatic Cancer
December 10, 2025
 · 
8 min read
Press Releases
BenchSci Extends ASCEND Agreement with Merck to Support Preclinical Disease Biology Research
December 10, 2025
 · 
2 min read
Load More